NP
DXCM icon

Nilsine Partners’s DexCom DXCM Stock Holding History

Nilsine Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,355
Closed -$220K – 335
2023
Q3 		$220K Sell
2,355
-3
-0.1% -$338 0.03% 316
2023
Q2 		$303K Buy
2,358
+35
+2% +$4.23K 0.04% 291
2023
Q1 		$270K Buy
+2,323
New +$260K 0.04% 296

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nilsine Partners's DXCM Position: Q4 2023 in Review

Nilsine Partners sold out of DexCom (DXCM) in Q4 2023, closing a stake of 2,355 shares — an estimated $220K sold.

Nilsine Partners first reported a position in DXCM in Q1 2023 and held it in 3 quarters. The position peaked at $303K in Q2 2023. 974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • Nilsine Partners reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
  • Nilsine Partners sold 2,355 DexCom shares in Q4 2023, an estimated $220K.
  • Nilsine Partners first reported a position in DexCom in Q1 2023 and held it in 3 quarters.
  • Nilsine Partners's DexCom position peaked at $303K in Q2 2023.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Nilsine Partners's 13F filing for Q4 2023, filed 24 Jan 2024.